Here's the latest on Viela Bio’s planned IPO By: Washington Business Journal via Business Journals September 23, 2019 at 14:05 PM EDT The planned IPO comes less than two years after the Gaithersburg biotech spun out of MedImmune, the former R&D division of AstraZeneca. Read More >>
